XML 37 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Allowance for doubtful accounts $ 0   $ 0   $ 0
Research and development cost 22,500 $ 114,620 79,939 $ 184,301  
Impairment charge   $ 69,178      
Uncertain tax positions 0   0   0
Cash equivalents $ 0   $ 0   $ 0
Warrants          
Antidilutive Excluded from Computation of Earnings Per Share, Amount     950,000 975,000  
Option          
Antidilutive Excluded from Computation of Earnings Per Share, Amount     12,180,500